SMAD3 and hepatocellular carcinoma: The latest study by Nagata et al showed that the inhibition of JNK shifts Smad3 signaling from oncogenesis to tumor-suppression in DEN induced rat hepatocellular carcinoma [31], suggesting that JNK is a key conductor in the switch in Smad3 signaling.